Trial Profile
A Phase III Multicentre, Randomized, Unblinded Clinical Trial to Test the Effect of Treatment With Recombinant LH Prior to Controlled Ovarian Stimulation in Poor Ovarian Responder Women With an Advanced Maternal Age
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Lutropin alfa (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms PRE-LH
- 04 Aug 2020 Planned End Date changed from 1 Jun 2021 to 31 May 2023.
- 04 Aug 2020 Planned primary completion date changed from 1 Mar 2020 to 31 May 2023.
- 06 Mar 2019 Status changed from not yet recruiting to recruiting.